Kiniksa (NASDAQ: KNSA) CEO awarded options, RSUs and PSUs, covers tax
Rhea-AI Filing Summary
Kiniksa Pharmaceuticals International, plc director and CEO Sanj K. Patel reported equity compensation grants and related share movements. On April 1, 2026, he received a grant of 120,150 share options with an exercise price of $48.13 per share, expiring on March 31, 2036, which vest over time starting April 1, 2026.
He was also granted 30,050 Restricted Share Units (RSUs) vesting over four years from April 1, 2026, and 60,100 Performance Share Units (PSUs), each representing a contingent right to receive Class A Ordinary Shares based on performance and vesting no later than January 30, 2029 at up to 200% of target.
In addition, previously granted RSUs totaling 21,327 units converted into the same number of Class A Ordinary Shares held indirectly through The Patel Family Irrevocable Trust of 2025. Of these, 10,313 shares were disposed of to satisfy tax obligations at $48.13 per share, leaving the trust with 71,014 shares. Separate trusts indirectly hold 109,795 and 51,794 Class A shares, reflecting substantial ongoing ownership.
Positive
- None.
Negative
- None.
Insights
CEO received large option, RSU and PSU awards; activity is routine compensation and tax withholding, not open-market trading.
Chairman and CEO Sanj K. Patel was granted 120,150 options at $48.13, plus RSUs and PSUs totaling 90,150 underlying shares. These awards vest over multi‑year schedules tied to continued service and, for PSUs, performance criteria certified by the compensation committee.
The filing also shows 21,327 RSUs converting into Class A Ordinary Shares, held indirectly via The Patel Family Irrevocable Trust of 2025, with 10,313 shares withheld at $48.13 to cover tax obligations. This F‑code disposition is not an open‑market sale. Indirect holdings across multiple trusts, including 71,014, 109,795, and 51,794 shares, indicate a sizable continuing equity position, suggesting these transactions are primarily administrative and compensation‑related rather than a directional market signal.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Share Option | 120,150 | $0.00 | -- |
| Grant/Award | Restricted Share Unit | 30,050 | $0.00 | -- |
| Grant/Award | Performance Share Unit | 60,100 | $0.00 | -- |
| Exercise | Restricted Share Unit | 6,481 | $0.00 | -- |
| Exercise | Restricted Share Unit | 6,237 | $0.00 | -- |
| Exercise | Restricted Share Unit | 8,609 | $0.00 | -- |
| Exercise | Class A Ordinary Share | 21,327 | $0.00 | -- |
| Tax Withholding | Class A Ordinary Share | 10,313 | $48.13 | $496K |
| holding | Class A Common Share | -- | -- | -- |
| holding | Class A Ordinary Share | -- | -- | -- |
Footnotes (1)
- Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 1, 2026. The RSUs vest over a four-year period, with 25% of the RSUs vesting on the vesting commencement date of April 1, 2026, and each yearly anniversary thereafter. Each Performance Share Unit (PSU) represents a contingent right to receive a number of Class A Ordinary Shares of the Issuer based upon the achievement of certain pre-established performance criteria, as certified by the Issuer's Compensation Committee. Unless earlier forfeited, each PSU vests and converts into not more than 200% of one Class A Ordinary Share of the Issuer no later than January 30, 2029, unless such date falls on a non-business date, in which case the next business date shall apply. The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2023. The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2024. The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2025.